Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study(INSPIRE) | unknown | — | 5,350 | Singlera Genomics Inc.INDUSTRY | 1 | Feb 21, 2025 | clinicaltrials |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | unknown | Phase 1 | 48 | Carisma Therapeutics IncINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT04675138 | Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care | unknown | — | 1,000 | National University Hospital, SingaporeOTHER | 6 | Oct 10, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT05991947 | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer | unknown | — | 1,100 | Zhejiang Cancer HospitalOTHER | 1 | Sep 5, 2024 | clinicaltrials |
| NCT06578858 | Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Analysis | unknown | — | 40 | Universidade Federal de PernambucoOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06486545 | Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer | unknown | N/A | 18 | Hunan Cancer HospitalOTHER | 0 | Aug 26, 2024 | clinicaltrials |
| NCT06475170 | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy | unknown | N/A | 60 | Northern Jiangsu People's HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06550063 | HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes(HERA) | unknown | — | 2,188 | St. James's Hospital, IrelandOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06006390 | CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | unknown | Phase 1 | 15 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05638269 | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | unknown | — | 12,000 | Zhujiang HospitalOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06521528 | A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test | unknown | — | 237 | Novomics. Co., Ltd.INDUSTRY | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06521541 | Whole Course Multi-model Prehabilitation to Improve Clinical Outcome in Patients Undergoing Neoadjuvant Treatment Prior to Gastrectomy | unknown | N/A | 90 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT06522542 | Gastric Cancer Complicated With Bleeding | unknown | — | 200 | Peking University Third HospitalOTHER | 0 | Jul 26, 2024 | clinicaltrials |
| NCT04798820 | The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)(SING) | unknown | N/A | 358 | Samsung Medical CenterOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06496789 | Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer | unknown | Phase 2 | 35 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 11, 2024 | clinicaltrials |
| NCT04278222 | Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) | unknown | Phase 2 | 24 | Shanghai Changzheng HospitalOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT05739045 | Nivolumab Combined With SOX Used in the Perioperative Treatment | unknown | Phase 2 | 46 | Xiangdong ChengOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT03760822 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients(SOCRATE) | unknown | Phase 2 | 112 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | unknown | Phase 2 | 107 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04891900 | TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma | unknown | N/A | 25 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 8, 2024 | clinicaltrials |
| NCT06489288 | ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer | unknown | N/A | 2,656 | Xijing HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06475417 | Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer | unknown | Phase 2 | 42 | Tang-Du HospitalOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06472063 | Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study(SNAC) | unknown | — | 684 | San Luigi Gonzaga HospitalOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06437678 | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06432205 | The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer | unknown | — | 121 | Peking UniversityOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04799548 | A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma | unknown | Phase 2 | 71 | Shanghai Zhongshan HospitalOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06419140 | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy | unknown | Phase 2 | 138 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06419244 | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06036563 | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing | unknown | — | 3,200 | Air Force Military Medical University, ChinaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05657080 | Cytosponge for Gastric Intestinal Metaplasia(CyGIM) | unknown | — | 226 | University of CambridgeOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06405009 | Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer | unknown | — | 450 | Northern Jiangsu People's HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06325891 | Microbiota in Gastric Cancer by Gastric Mucosal Brushing | unknown | — | 40 | King Chulalongkorn Memorial HospitalOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06396143 | Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration | unknown | — | 120 | Zhejiang UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06212700 | PRIORITY-CONNECT 2 Pilot Trial | unknown | N/A | 20 | Surgical Outcomes Research Centre (SOuRCe)NETWORK | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06383559 | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06383793 | Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy | unknown | — | 100 | Northern Jiangsu People's HospitalOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT03579784 | Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer | unknown | Phase 2 | 40 | Do-Youn OhOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04908813 | Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer | unknown | Phase 2 | 150 | Shanghai Henlius BiotechINDUSTRY | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06079554 | Microbiota and Metabolomics of Intestinal Type of Gastric Cancer | unknown | — | 32 | Jilin UniversityOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06362070 | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy | unknown | N/A | 75 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06186089 | Effect of Gastrectomy on Gut Microbiome and Cognitive Function | unknown | — | 45 | Jiangjiang BiOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06354036 | Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy | unknown | N/A | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT03835663 | The Bacterial Composition of the Stomach in Reflux Disease | unknown | — | 100 | Imperial College LondonOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06202716 | Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore | unknown | Phase 2 | 50 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT05823272 | ONS in Gastric Cancer After Total Gastrectomy | unknown | N/A | 60 | Jinling Hospital, ChinaOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT05420259 | Combined Exercise and Nutritional Intervention in GI Cancer Patients | unknown | N/A | 68 | Hospital Beatriz ÂngeloOTHER | 1 | Mar 19, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2025source: clinicaltrials